Decentralized Intelligence on your project data.

Qubigen partners with pharmaceutical companies, biotechs, and contract research organizations (CROs) to accelerate discovery timelines through generative tensor architectures and first-principles quantum chemistry (QM) runtimes. Organizations can engage through two primary operational pathways.

Platform Model (Decentralized Edge Deployments)

Decentralized Edge Deployments

For biotechs, pharma labs, and Discovery CROs looking to own their discovery workflows.

Qubigen hosts an isolated, air-gapped platform layer within a dedicated single-tenant environment. Your team runs automated generative design, property predictions, and quantum mechanics screening, turning proprietary project data into an exclusive competitive edge with zero raw data egress.

Managed Execution & Asset Co-Development

For teams seeking high-touch scientific execution without internal tool overhead. Qubigen’s expert team operates our generative tensor agents and first-principles QM runtimes directly on your compound series, delivering prioritized, synthetically feasible candidates and deep SAR analytics exclusively for your pipeline.